Humoral immune responses to the monovalent XBB.1.5-adapted BNT162b2 mRNA booster
U. Marking, O. Bladh, K. Aguilera, Y. Yang, N. Greilert-Norin, K. Blom, S. Hober, J. Klingstrom, S. Havervall, M. Aberg, D. J. Sheward, C. Thalin
This study shows that a monovalent XBB.1.5-adapted BNT162b2 booster vaccine enhances binding and neutralizing antibodies against XBB.1.5 and BA.2.86 in elderly individuals with prior vaccinations.
bioRxiv · Dec 21, 2023 · PreprintImmunology